Company Directory - Simulations Plus Inc
Company Details - Simulations Plus Inc
Simulations Plus Inc
WebsiteLancaster, USA
Simulations Plus Inc. is a provider of modeling and simulation software and services tailored for drug development and pharmaceutical research. The company leverages advanced analytical platforms to streamline R&D processes and support decision-making across the life sciences industry.
CCI Score
CCI Score: Simulations Plus Inc
60.68
-0.04%
Latest Event
Simulations Plus Supports Majority of FDA-Approved Drugs in 2024
The article highlights how Simulations Plus Inc's advanced modeling and simulation technology significantly accelerated the development of the majority of FDA-approved drugs in 2024, marking a notable positive contribution to global healthcare innovation.
Take Action
So what can you do? Support Simulations Plus by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
LEADER
Simulations Plus Inc is currently rated as a Leader.
Latest Events
- JAN142025
The article highlights how Simulations Plus Inc's advanced modeling and simulation technology significantly accelerated the development of the majority of FDA-approved drugs in 2024, marking a notable positive contribution to global healthcare innovation.
+80
Technology and Services Impact
March 26
Simulations Plus demonstrated a strong positive impact in the realm of Technology and Services Impact. Their simulation and modeling software played a critical role in accelerating drug development for a majority of FDA-approved drugs in 2024, thereby enhancing global healthcare outcomes. This contribution stands in stark contrast to behaviors that enable oppressive regimes, reinforcing the company’s positive role in advancing life-saving technologies.
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
- JAN012023
Simulations Plus has updated its corporate human rights policy, reaffirming its commitment to upholding international human rights standards, ensuring fair labor practices, anti-discrimination measures, and a safe workplace. This policy initiative reflects positively on the company’s ethical responsibilities and its stance against oppressive practices.
+85
Business Practices and Ethical Responsibility
March 26
Simulations Plus has demonstrated a robust commitment to human rights through its updated corporate policy, which emphasizes fair compensation, respect for labor rights, anti-discrimination measures, and a safe working environment. By aligning its practices with international standards and ensuring transparency in enforcing these policies, the company stands in opposition to exploitative labor practices and authoritarian norms. However, while the policy is comprehensive, further clarity on enforcement mechanisms could enhance accountability.
- NOV172022
Simulations Plus demonstrates a strong commitment to ESG principles through extensive academic support, corporate philanthropy, and the development of innovative simulation software that reduces risks in drug development, ultimately contributing to societal welfare and resisting exploitative practices.
+70
Public and Political Behavior
March 26
The company actively engages in community volunteerism, academic sponsorship, and local philanthropy. These initiatives help foster democratic values and public engagement, countering authoritarian practices by supporting social and educational development.
Environmental, Social and Governance (ESG) - Simulations Plus
+80
Business Practices and Ethical Responsibility
March 26
Simulations Plus's strong ethical framework is evident through its generous academic support, free reference site licenses for non-profit research, significant discounts for government and non-profit organizations, and sustained corporate philanthropy. These practices not only promote educational advancement but also serve as a counterbalance to exploitative capitalist practices.
Environmental, Social and Governance (ESG) - Simulations Plus
+75
Technology and Services Impact
March 26
The innovative simulation and modeling software developed by Simulations Plus plays a key role in reducing unnecessary animal testing and clinical risks by enabling efficient in silico analysis in drug development. This technological solution not only enhances public health but also contributes positively to social welfare.
Environmental, Social and Governance (ESG) - Simulations Plus
- DEC312020
The 2020 ESG Report underscores Simulations Plus Inc's commitment to sustainability, ethical business practices, and respect for human rights, indicating a positive stance against authoritarian practices.
+80
Business Practices and Ethical Responsibility
March 26
The ESG report demonstrates that Simulations Plus Inc is proactively engaging in ethical business practices. Their focus on reducing environmental impact, promoting diversity and inclusion, ensuring data security, and upholding human rights reflects a genuine commitment to practices that oppose authoritarianism and unethical corporate behavior.
Simulations Plus Inc 2020 ESG Report – SustainabilityReports.com
- JAN012020
The ESG report highlights Simulations Plus Inc's comprehensive approach to environmental, social, and governance practices. The report celebrates the company's strong board diversity, robust risk management practices, ethical business guidelines, and advanced simulation technologies that optimize drug development. These initiatives demonstrate a commitment to transparency, inclusivity, and responsible corporate behavior that stands in opposition to authoritarian practices.
+80
Public and Political Behavior
March 26
The report details effective corporate governance, board diversity, and risk management practices which suggest that the company engages in transparent political behavior without aligning with authoritarian activities.
+85
Business Practices and Ethical Responsibility
March 26
Simulations Plus Inc. demonstrates strong ethical responsibility through its comprehensive ESG practices, including clear corporate ethics, vendor management, and proactive measures addressing human rights and workplace diversity. These practices reflect an ethical stance that is counter to any authoritarian tendencies.
+80
Technology and Services Impact
March 26
The company uses advanced simulation and modeling technologies for drug research and development, which not only support public health but also avoid the deployment of repressive technologies. This reflects a constructive impact through technology.
+75
Economic and Structural Influence
March 26
The firm shows modest economic and structural influence, primarily focused on supporting pharmaceutical research and development. There is no evidence of economic activities that bolster authoritarian regimes or practices.
Alternatives
Sunnyvale, USA
-8.35
San Francisco, USA
-28.77
Dublin, Ireland
62.72
Zug, Switzerland
58.48
San Jose, United States
45.98
Tokyo, Japan
36.97
India
29.18
Dublin, Ireland
16.53
Mill Valley, United States
12.21
Houston, United States
11.62
Industries
- 541511
- Custom Computer Programming Services
- 511210
- Software Publishers
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)